Summary
Elevance Health, Inc. (formerly Anthem, Inc.) filed an 8-K on May 18, 2017, detailing key corporate governance and shareholder matters approved at their Annual Meeting. The most significant outcomes for investors include the approval of the 2017 Anthem Incentive Compensation Plan, which governs executive and employee compensation, and amendments to the company's Articles of Incorporation and Bylaws. These amendments primarily grant shareholders the ability to amend the company's Bylaws, enhancing shareholder rights and corporate governance. Additionally, the report confirms the election of directors and the ratification of Ernst & Young LLP as the independent auditor. Shareholders also provided an advisory vote on executive compensation, approving it, and overwhelmingly favored an annual frequency for such advisory votes going forward. These actions signal proactive corporate governance and a commitment to aligning executive incentives with shareholder interests.
Key Highlights
- 1Shareholders approved the 2017 Anthem Incentive Compensation Plan, outlining the framework for executive and employee rewards.
- 2Amendments to the Articles of Incorporation were approved, empowering shareholders with the ability to amend the company's Bylaws.
- 3The company's Bylaws were amended to reflect the shareholder ability to amend them and to remove references to a disbanded Executive Committee.
- 4Directors R. Kerry Clark and Robert L. Dixon, Jr. were elected to serve three-year terms.
- 5Ernst & Young LLP was ratified as the company's independent registered public accounting firm for 2017.
- 6Shareholders approved an advisory vote on executive compensation, indicating support for the company's compensation practices.
- 7An overwhelming majority of shareholders voted for an annual frequency for advisory votes on executive compensation.